| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3414 | |||||||||||||||||||||||
| Submitter : | Mr. Michael Fitzpatrick | Date & Time: | 12/18/2006 09:12:45 | |||||||||||||||||||||
| Organization : | Mr. Michael Fitzpatrick | |||||||||||||||||||||||
| Category : | Drug Association | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I sincerely urge the both the federal govenment as well as private industry to seek vaccines that are not in any way derived from aborted fetus stem cell lines. There are already alternative to some of these fetus stem cell lines. There is never justification for the taking of innocent human life, be from the first moment of conception to natural death. | ||||||||||||||||||||||||